NCT05786521CompletedPhase 4
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
The Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Biomarkers of Aging in Older Overweight/Obese Adults With Insulin Resistance
Source: ClinicalTrials.gov · Last updated 4 May 2025
Brief summary (registry, in English)
Semaglutide is a medication approved by the US Food and Drug Administration (FDA) as an antihyperglycemic (a drug that reduces glucoses in those with diabetes) and for weight management. This new study will help find out what effects, semaglutide has on people who take the drug and the drug's effect on physical function, body composition, and aging.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 2 Mar 2023
- Start date
- 1 Apr 2023
- Primary completion date
- 20 May 2024
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT05786521
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 20
- From 1 Apr 2023 to the primary completion date, 20 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have heart disease
- Have liver disease
Other
- Smoke
Who the study is looking for
- Older than 65
- Have prediabetes or diabetes
- BMI ≥ 27.0 kg/m2
- Living independently (not in assisted living or nursing home)
Age in the registry: 65 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Health San Antonio Coordinator of this site? Confirm its status | San Antonio | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.